This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Interim Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Fabi Nahab interview Dr. Mitch Elkind about his paper on The Northern Manhattan Study. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about don't get caught with a "bovine arch." The podcast concludes where Dr. Jason Mackey interviews Dr. Daniel Claassen for the Lesson of the Week segment about the Resident & Fellow Section paper about orbital bruits. The participants had nothing to disclose except for Drs. Elkind, Claassen and Mackey.Dr. Elkind serves as Resident and Fellow Section Editor for Neurology; serves as a consultant to Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline, Jarvik Heart, Tethys Bioscience, Inc., and Daiichi-Sankyo; serves on speakers' bureaus for Boehringer-Ingelheim, Inc., and Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; and receives research support from diaDexus, Inc., Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, and from the NIH/NINDS [# K23 NS42912 (PI), # R01 NS050724 (PI),#NS048134 (PI), # P50 NS049060 (Project PI), # R37 NS029993 (Co-PI), and #R01 NS55809 (Co-I)]; and has given expert testimony on behalf of Merck Serono (Vioxx® litigation), Pfizer Inc (Shiley valve and Celebrex®/Bextra® litigation), and Novartis (Zelnorm® and stroke litigation). Dr. Claassen is a recipient of the AAN Clinical Research Training Fellowship.Dr. Mackey is funded by NIH T-32 training grant [NS 047996-04].

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related